The use of dental implants has steadily increased and in recent years the largest increase has been noted in patients aged between 65-74 years. This age group are also likely to be on long-term prescription of antiplatelet and oral anticoagulants as prophylaxis against thromboembolic events. Dental implant placement as a surgical procedure presents a risk [read the full story…]
We take a look at the recently updated guidance on the Management of Dental Patients Taking Anticoagulants or Antiplatelet Drug from the Scottish Dental Clinical effectiveness programme (SDCEP).
[read the full story...]
This review of bleeding complications in patients on dual antiplatelet therapy compared to patients on single antiplatelet or no antiplatelet therapy for patients undergoing oral surgery included 16 studies but no randomised trials. Findings suggest that dual antiplatelet therapy should not be discontinued but the evidence is of low quality.
[read the full story...]
This review the bleeding risk of patients continuing or discontinuing oral anticoagulant therapy found no increase bleeding risk in those continuing anticoagulant therapy.
[read the full story...]
This new guidance from the Scottish Dental Clinical Effectiveness Programme (SDCEP) provides recommendations for dental patients taking anticoagulants or antiplatelet drugs
[read the full story...]
Caroline Struthers appraises a recent US cross-sectional study of the use of medications of “questionable benefit” in nursing home residents with advanced dementia. She concludes that all medications are of questionable value if they have side effects which might have a negative impact on quality of life or are likely to cause harm.
[read the full story...]
